Source Stoxx Europe 600 Opt Insuran (0MTC) 시세

Sounds like X you don't like me.  I think you are actually mad at yourself.

Have a good day, get a puppy or something.

X

LMAO... pure BS.... Folks be careful on this kind of made up opinions with the same cut and paste that is used daily...... Stick with your our DD facts and info from reliable posters.....

Are you confused? that post is all about this ticker. I call that a "pay no attention to the man behind the curtain" comment.

This is nothing but nonsense cut and post BS.... third grader can write better than this.... Has nothing to do with RDAR.......

Oh I know lol. I caught the sarcasm i was just saying. GLTY

BTAI...................................................................................p/m

Feels like last ditch effort to get some better terms. The indemnification in the RC deal does get under my skin.

My posts are unassailable because they include quotes from the company's own print. I know it is frustrating. 🤭 They are continue to through the existing conversions using the GlobeTopper acquisition story. I guess we will have to wait for the next filing to see where the $1 million in cash

hyperopia, must be my memory, I was recalling the FW units not being delivered yet at the ASM but I was assuming they were ordered at the time of the Feb PR. I agree if the units were not yet ordered at June ASM there is no shot at them being qualified and I agree with your timing projection, thx.

Good to see the TNXP leadership team picking up some shares!!!!

AREC........................https://stockcharts.com/h-sc/ui?s=AREC&p=W&b=5&g=0&id=p86431144783

Most obvious exit $$$$ at $2.98 if breaks $2.64 solid 

style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px"... the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing

Of course this will be one of the analyst questions today. Not.

You think that maybe Lionheart partnered with EMED to possibly do a buyout and take Lionheart public?   Just a thought. 

Pump it $2.46 now +'50%

Let the March begin for the countdown of great things to come!! ELTP$$$$$$$ 7.11👍

Well, another Friday of a week of nothing, after 3 years of nothing. What a great streak by the great CEO. Makes the trolls proud.
Now, there's pumpers showing bull emogis and whining.
FOXO in the teens and heading down.
But, to the pumpers..."there's a plan". 🤣🤣

NVDS $26.42 Either one works a little less risk on NVDS is obvious. Must hold $25.90 for. Breakout to $28.
That implies NVDA final bottom at $116- $118. 

style="caret-color: rgb(72, 74, 78); color: rgba(72, 74, 78, 1); font-family: "IBM Plex Sans", sans-serif; background-color

AES +.32 to 10.70 in pre-market after posting solid Q4 earnings and upside FY25 guidance .... I added some shares in pre-market and am surprised it's not up even more ....

briefing -

AES beats by $0.19, misses on revs; guides FY25 EPS above consensus (10.38 ) :
R

TTX Cure to cancer Runned by a scam artist Ceo Fitzgerald, Step down and this company will soar to a billion market cap

Are tech companies any closer to developing a cannabis breathalyzer?

https://www.marijuanaventure.com/are-tech-companies-any-closer-to-developing-a-cannabis-breathalyzer/

"For many of the 24 states that still do not allow adult-use cannabis, concerns about intoxicated d

1) Who cares? We already know there's no $ in that space.

2) Y90 has no shelf life. Would have to have local infrastructure/manufacturing setup in parallel with regulatory applications, as having that in place to local standards that would be part of the approval process. Would be

Kraig Labs expects this will be a pivotal year for industry integration of spider silk.
“Our production team is on track to deliver commercial quantities of our spider silk this year,
OK I'm ready. I guess I'll go ahead and order that new truck I want. Why not? This is sure to happen,

TRNR..........................https://stockcharts.com/h-sc/ui?s=TRNR&p=W&b=5&g=0&id=p86431144783

DKL for the first time gave guidance in their recent earnings release: 20% EBITDA growth for the 2025 year. This for a company with a 10% yield that's increased dividends every quarter since 2020 and every year since 2015. No brainer.